search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


66 resulaten gevonden voor Dutch Cancer Society in trials

Staging laparoscopy combined with ultrasonography and near-infrared fluorescence imaging to detect occult pancreatic metastases
- TRIAL ID
NTR6639
- ACRONYM
Choice between stoma and neobladder after bladder removal for bladder cancer
- TRIAL ID
NTR6460
- ACRONYMDEDUCT study
Krachttraining en eiwitsuppletie ter preventie van bijwerkingen van hormonale behandeling bij mannen met prostaatkanker.
- TRIAL ID
NTR6432
- ACRONYMTraining and protein during ADT in prostate cancer
Chemotherapy and surgery versus surgery alone for colorectal cancer with metastases in the peritoneum
- TRIAL ID
NTR6301
- ACRONYMCAIRO6
Physical Activity and Dietary intervention in OVArian cancer (PADOVA)
- TRIAL ID
NTR6300
- ACRONYMPADOVA
Informing Patients about Symptom Distress
- TRIAL ID
NTR6153
- ACRONYMINSTRUCT
De implementatie van een effectieve interventie om te stoppen met roken voor ouders.
- TRIAL ID
NTR6092
- ACRONYMN.A.
The CORRECT-study
- TRIAL ID
NTR6025
- ACRONYMThe CORRECT-study
Tailoring information to older colorectal cancer patients: Effects of using a web-based patient-directed tool
- TRIAL ID
NTR5919
- ACRONYMOCA-2
PORTEC-4a, een onderzoek naar de waarde van een individueel moleculaire risicoprofiel om de nabehandeling na operatie voor vroeg stadium baarmoederkanker (endometriumcarcinoom) te bepalen.
- TRIAL ID
NTR5841
- ACRONYMPORTEC-4a
CHOICE: CHOosing treatment together In Cancer at the End of life
- TRIAL ID
NTR5489
- ACRONYMCHOICE
Accuracy of glioma imaging
- TRIAL ID
NTR5354
- ACRONYMFRONTIER
Pomalidomide combined with Carfilzomib and Dexamethasone (PCd) for induction and consolidation followed by Pomalidomide combined with Dexamethason vs Pomalidomide maintenance for patients with Multiple Myeloma in progression after prior 1st line treatment with Lenalidomide and Bortezomib.
- TRIAL ID
NTR5349
- ACRONYMHOVON 114 MM
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastases
- TRIAL ID
NTR4893
- ACRONYMCHARISMA
Adherence makes perfect: Improving the adherence of practice nurses to smoking cessation guidelines
- TRIAL ID
NTR4436
- ACRONYMAMP
The SWORD-study: Managing fear of cancer recurrence.
- TRIAL ID
NTR4423
- ACRONYMThe SWORD-Study
Natural killer cell infusion after stem cell transplantation for leukemia
- TRIAL ID
NTR4403
- ACRONYMIL-15 activated NK cells
Enteral versus parenteral feeding in pediatric oncology patients with gastro-intestinal mucositis
- TRIAL ID
NTR4099
- ACRONYMN/A
Interventions for fatigued palliative cancer patients.
- TRIAL ID
NTR3812
- ACRONYMTIRED
Enhancing patient communication in oncology consultations.
- TRIAL ID
NTR3779
- ACRONYMPatientTIME
Interaction study of Docetaxel + Tolbutamide and Milk Thistle.
- TRIAL ID
NTR3611
- ACRONYM
PORTEC-4: Randomised trial investigating the role and optimal dose of vaginal brachytherapy for endometrial cancer.
- TRIAL ID
NTR3263
- ACRONYMPORTEC-4
Randomized multicentre phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in patients with high risk primary rectal cancer compared to standard preoperative chemoradiotherapy, surgery and optional adjuvant chemotherapy.
- TRIAL ID
NTR3230
- ACRONYMRAPIDO
A multicenter, randomized phase III study of bortezomib and dexamethasone compared with dexamethasone alone as induction treatment followed by high dose melphalan (HDM) and autologous stem cell transplantation (SCT) in patients with de novo amyloid light chain (AL) amyloidosis.
- TRIAL ID
NTR3220
- ACRONYMHOVON 104 AL Amyloidosis
The Signal-Trial: Evaluation of a screening tool for psychosocial problems in cancer genetics.
- TRIAL ID
NTR3205
- ACRONYMSignaal-trial
A randomized phase II study for evaluation of T cell depleted non myeloablative allogeneic stem cell transplantation followed by early consolidation with lenalidomide or lenalidomide combined with bortezomib and subsequent DLI for patients with multiple myeloma in progression or relapse following first line therapy.
- TRIAL ID
NTR2958
- ACRONYMHOVON 108 MM
Vruchtbaarheid, eicelvoorraad en vervroegde overgang bij Nederlandse vrouwen die in hun jeugd kanker hebben gehad .
- TRIAL ID
NTR2922
- ACRONYMVEVO-onderzoek
Hyperplastic polyposis syndrome: Endoscopic treatment and surveillance.
- TRIAL ID
NTR2757
- ACRONYMHPSB
Effects and usability of Cancer Risk Test (KRT).
- TRIAL ID
NTR2748
- ACRONYMPilot-study KRT
Image guided Pre-operative Accelerated partial Breast Irradiation (PAPBI): Defening radiotherapy sensivity.
- TRIAL ID
NTR2633
- ACRONYMPAPBI
Sexual functioning and the quality of sexual life in patients with colorectal cancer and their partners.
- TRIAL ID
NTR2568
- ACRONYM
A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma.
- TRIAL ID
NTR2528
- ACRONYMHOVON 95 MM
A-CaRe study 3: Exercise intervention after stem cell transplantation.
- TRIAL ID
NTR2341
- ACRONYMEXIST
Prevention and treatment of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial.
- TRIAL ID
NTR2252
- ACRONYMHOVON 96 GVHD
PACES: Physical exercise during Adjuvant Chemotherapy Effectiveness Study.
- TRIAL ID
NTR2159
- ACRONYMPACES
A Phase II randomized multicenter study to assess the efficacy of lenalidomide with or without erythropoietin and granulocyte-colony stimulating factor in patients with low and intermediate-1 risk myelodysplastic syndrome.
- TRIAL ID
NTR1825
- ACRONYMHOVON 89 MDS
Randomized maintenance therapy with Azacitidine (Vidaza) in older patients (>= 60 years of age) with acute myeloid leukemia (AML) and refractory anemia with excess of blasts (RAEB, RAEB-t).
- TRIAL ID
NTR1810
- ACRONYMHOVON 97 AML
Bortezomib maintenance therapy in newly diagnosed patients with mantle cell lymphoma, responsive on rituximab combined with CHOP and high dose Ara-C and after BEAM with auto PSCT rescue.
- TRIAL ID
NTR1772
- ACRONYMHOVON 75 MCL
Functionele beeldvorming bij kanker van de dikke darm of endeldarm.
- TRIAL ID
NTR1764
- ACRONYMMICC
An explorative study on physiological and neurophysiological determinants of fatigue in cancer survivors.
- TRIAL ID
NTR1685
- ACRONYMFICS (Fatigue In Cancer Survivors)
Two new screenings technics for the early detection of pancreatic neuroendocrine tumors in Multipele Endocrine Neoplasia type 1 (MEN1) and Von Hippel-Lindau disease (VHL).
- TRIAL ID
NTR1668
- ACRONYMEUS and HTP PET for PNET in MEN1 and VHL.
Quality of Life in Motion: A combined physical exercise and psychosocial training program to improve physical fitness in children with cancer.
- TRIAL ID
NTR1531
- ACRONYMQLIM
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II study
- TRIAL ID
NTR1461
- ACRONYMHOVON 88 CLL
Phase I/II trial of Lenalidomide plus Bortezomib combined with Dexamethasone in patients in 1st relapse or primary refractory after first line therapy for Multiple Myeloma.
- TRIAL ID
NTR1440
- ACRONYMHOVON 86 MM
Investigation of the treatment of ovarian cancer with p53-peptide vaccination after pretreatment with cyclofosfamide
- TRIAL ID
NTR1407
- ACRONYMISA-p53-CTX
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.
- TRIAL ID
NTR1380
- ACRONYMHOVON 85 NHL
ANTI-CD20 THERAPY FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
- TRIAL ID
NTR1222
- ACRONYMN/A
Patient informed choice between palliative chemotherapy and best supportive care.
- TRIAL ID
NTR1113
- ACRONYMN/A
Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab maintenance in elderly patients (66-80 years) with diffuse large B-cell lymphoma
- TRIAL ID
NTR1014
- ACRONYMHOVON 84 NHL
High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study.
- TRIAL ID
NTR988
- ACRONYMHigh dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study
RCT in breast cancer genetic counselling.
- TRIAL ID
NTR887
- ACRONYMRCT in breast cancer genetic counselling
HYpofractionated irradiation for PROstate cancer
A randomized multicenter phase III study.
- TRIAL ID
NTR759
- ACRONYMHYPRO study
Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma: PORTEC-3.
- TRIAL ID
NTR729
- ACRONYMPORTEC-3
The SHAPE study.
- TRIAL ID
NTR723
- ACRONYMSHAPE: Sex Hormones and Physical Exercise
Imatinib in combination with Cytarabine as compared to Imatinib alone in patients with first chronic phase Chronic Myeloid Leukemia. A prospective randomized phase III study.
- TRIAL ID
NTR674
- ACRONYMHOVON 78 CML
Alemtuzumab as remission induction for adult patients with acute lymphoblastic leukemia in relapse; A randomized phase II study.
- TRIAL ID
NTR673
- ACRONYMHOVON 74 ALL
Reduced intensity chemotherapy given with and without Imatinib Mesylate in patients >= 60 years considered unfit for standard chemotherapy with previously untreated Acute Myeloid Leukemia (AML) and refractory anemia with excess of Blasts (RAEB, RAEB-T); A randomized phase II study.
- TRIAL ID
NTR655
- ACRONYMHOVON / SAKK AML - 67
Randomized phase III study of Rituximab with intensified CHOP chemotherapy vs. Rituximab with High-Dose Sequential Therapy and Autologous Stem Cell Transplantation in Adult Patients (18-65 yrs) with Stage II-IV High-intermediate or High Risk DLBCL.
- TRIAL ID
NTR556
- ACRONYMHOVON 63 NHL
A randomized phase III study in previously untreated patients with biological high-risk CLL: Fludarabine + cyclophosphamide (FC) versus FC + low-dose alemtuzumab.
- TRIAL ID
NTR529
- ACRONYMHOVON 68 CLL
CROSS II.
- TRIAL ID
NTR487
- ACRONYMCROSS II
PORTEC-2: Postoperative Radiation Therapy for Endometrial Carcinoma – a multicenter randomised phase III trial comparing external beam radiation and vaginal brachytherapy.
- TRIAL ID
NTR332
- ACRONYMPORTEC-2
The effect of comprehensive counseling by a nurse specialist on depressive symptoms and quality of life: A prospective randomized study in patients with head and neck cancer.
- TRIAL ID
NTR257
- ACRONYMNUCAI
Evaluation of intervention strategies to manage fatigue during active treatment and to prevent persistent fatigue after curative treatment for cancer.
- TRIAL ID
NTR183
- ACRONYMN/A
Cognitive Behaviour Therapy to reduce severe fatigue and impairment in daily life after curative treatment for cancer.
- TRIAL ID
NTR107
- ACRONYMN/A
Communicating breast cancer risks: a genetic counsellor's role in improving patient understanding to increase informed decision-making.
- TRIAL ID
NTR89
- ACRONYMBRISC
Patient involvement in prostate cancer treatment decisions.
- TRIAL ID
NTR63
- ACRONYMN/A